Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019 Mar 13;11(3):615.
doi: 10.3390/nu11030615.

Fat Quantity and Quality, as Part of a Low-Fat, Vegan Diet, Are Associated with Changes in Body Composition, Insulin Resistance, and Insulin Secretion. A 16-Week Randomized Controlled Trial

Affiliations
Randomized Controlled Trial

Fat Quantity and Quality, as Part of a Low-Fat, Vegan Diet, Are Associated with Changes in Body Composition, Insulin Resistance, and Insulin Secretion. A 16-Week Randomized Controlled Trial

Hana Kahleova et al. Nutrients. .

Abstract

Macronutrient composition of the diet influences the development of obesity and insulin resistance. The aim of this study was to assess the role of dietary fat quantity and fatty acid composition in body composition, insulin resistance, and insulin secretion. An open parallel randomized trial design was used. Overweight participants (n = 75) were randomized to follow a low-fat vegan (n = 38) or control diet (n = 37) for 16 weeks. Dual X-ray absorptiometry was used to measure body composition. Insulin resistance was assessed with the Homeostasis Model Assessment (HOMA-IR) index. Insulin secretion was assessed after stimulation with a liquid breakfast (Boost Plus, Nestle, Vevey, Switzerland). Self-reported 3-day diet records were used to assess dietary intake. A linear regression model was used to test the relationship between fat intake and body composition, insulin resistance, and insulin secretion. Changes in fat intake expressed as percent of total energy consumed correlated positively with changes in fat mass (r = 0.52; p < 0.001; and 0.347; p = 0.006, respectively), even after adjustment for changes in body-mass index (BMI) and energy intake (0.33; p = 0.01). Decreased intakes of C18:0 (r = 0.37, p = 0.004) and CLA-trans-10-cis12 (r = 0.40, p = 0.002), but increased intake of C18:2 (r = -0.40, p = 0.002) and C18:3 (p = -0.36, p = 0.006), were associated with a decrease in HOMA-IR, independent on changes in BMI and energy intake. The main fatty acids associated with changes in fasting insulin secretion were C12:0 (r = -0.31, p = 0.03), and TRANS 16:1 (r = -0.33, p = 0.02), both independent on changes in BMI and energy intake. Our findings demonstrate that, in the context of a low-fat vegan diet, decreased intake of saturated and trans fats and increased relative content of polyunsaturated fatty acids, particularly linoleic and α-linolenic acids, are associated with decreased fat mass and insulin resistance, and enhanced insulin secretion.

Keywords: diet; fat; fatty acids; nutrition; plant-based; vegan.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Enrollment of the Participants and Completion of the Study.
Figure 2
Figure 2
Changes in fatty acid profiles between vegans and controls at baseline and 16 weeks. (A) Control Baseline, (B) Vegan Baseline (C) Control Final, (D) Vegan Final. MUFA, monounsaturated fatty acid; PUFA, polyunsaturated fatty acid.
Figure 3
Figure 3
Regression models for changes in fatty acid intake and changes in body composition, insulin resistance, and insulin secretion. (A) Total fat intake and change in fat mass: r = 0.52; p < 0.001; (B) Intake of TRANS 18:2 and change in percentage of body fat: r = 0.35; p = 0.004; (C) Intake of C18:0 and changes in Homeostasis Model Assessment (HOMA-IR) index: r = 0.37, p = 0.004; (D) Intake of CLA-trans10-cis12 and changes in HOMA-IR: r = 0.40, p = 0.002; (E) Intake of C18:2 and changes in HOMA-IR: r = −0.36, p = 0.006; (F) Intake of C18:3 and changes in HOMA-IR: r = −0.40, p = 0.002; (G) Intake of C12:0 and changes in fasting insulin secretion: r = −0.31, p = 0.03; (H) Intake of TRANS 16:1 and changes in fasting insulin secretion: r = −0.33, p = 0.02.

References

    1. Field C.J., Ryan E.A., Thomson A.B., Clandinin M.T. Diet fat composition alters membrane phospholipid composition, insulin binding, and glucose metabolism in adipocytes from control and diabetic animals. J. Biol. Chem. 1990;265:11143–11150. - PubMed
    1. Hodson L., Skeaff C.M., Fielding B.A. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary intake. Prog. Lipid Res. 2008;47:348–380. doi: 10.1016/j.plipres.2008.03.003. - DOI - PubMed
    1. Vessby B. Dietary fat, fatty acid composition in plasma and the metabolic syndrome. Curr. Opin. Lipidol. 2003;14:15–19. doi: 10.1097/00041433-200302000-00004. - DOI - PubMed
    1. Vessby B., Uusitupa M., Hermansen K., Riccardi G., Rivellese A.A., Tapsell L.C., Nälsén C., Berglund L., Louheranta A., Rasmussen B.M., et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU Study. Diabetologia. 2001;44:312–319. doi: 10.1007/s001250051620. - DOI - PubMed
    1. Risérus U., Willett W.C., Hu F.B. Dietary fats and prevention of type 2 diabetes. Prog. Lipid Res. 2009;48:44–51. doi: 10.1016/j.plipres.2008.10.002. - DOI - PMC - PubMed

Publication types